Answers are grounded in this paper and cite their sources.
Retrospective analysis determines prevalence and treatment patterns in patients with CDKL5 deficiency disorder, indicating healthcare resource usage.
To determine prevalence, treatment patterns, and healthcare resource utilization (HCRU) in patients with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) using US claims data.
No takes yet. Share an insight, caveat, or question.
Amin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: